ClinVar Miner

Submissions for variant NM_020366.4(RPGRIP1):c.1107del (p.Glu370fs)

dbSNP: rs61751266
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 15
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001047199 SCV001211139 pathogenic Cone-rod dystrophy 13; Leber congenital amaurosis 6 2023-02-08 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Glu370Asnfs*5) in the RPGRIP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPGRIP1 are known to be pathogenic (PMID: 11528500, 23105016). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Leber congenital amaurosis (PMID: 11283794, 20079931, 24997176, 30202406). This variant is also known as Lys342(1-bp del). ClinVar contains an entry for this variant (Variation ID: 99809). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Centogene AG - the Rare Disease Company RCV000171128 SCV001426643 pathogenic Leber congenital amaurosis 6 criteria provided, single submitter clinical testing
DBGen Ocular Genomics RCV000171128 SCV001815997 pathogenic Leber congenital amaurosis 6 2021-06-23 criteria provided, single submitter clinical testing
Revvity Omics, Revvity RCV000086238 SCV002019890 pathogenic not provided 2021-02-03 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000171128 SCV002044747 pathogenic Leber congenital amaurosis 6 2021-11-07 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001800395 SCV002044758 pathogenic Cone-rod dystrophy 13 2021-11-07 criteria provided, single submitter clinical testing
3billion RCV001800395 SCV002058264 pathogenic Cone-rod dystrophy 13 2022-01-03 criteria provided, single submitter clinical testing Frameshift: predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000099809, PMID:11283794). It is not observed in the gnomAD v2.1.1 dataset (PM2_M).. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.
Al Jalila Children's Genomics Center, Al Jalila Childrens Speciality Hospital RCV000086238 SCV002818118 pathogenic not provided 2022-12-17 criteria provided, single submitter clinical testing
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center RCV000171128 SCV004806819 pathogenic Leber congenital amaurosis 6 2024-03-26 criteria provided, single submitter clinical testing
OMIM RCV000171128 SCV000025451 pathogenic Leber congenital amaurosis 6 2001-05-01 no assertion criteria provided literature only
Retina International RCV000086238 SCV000118384 not provided not provided no assertion provided not provided
Molecular Genetics Laboratory, Institute for Ophthalmic Research RCV000786015 SCV000924655 pathogenic Leber congenital amaurosis 2017-12-13 no assertion criteria provided research
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City RCV000171128 SCV001133096 pathogenic Leber congenital amaurosis 6 2019-09-26 no assertion criteria provided clinical testing
Laboratory of Genetics in Ophthalmology, Institut Imagine RCV000171128 SCV001438576 pathogenic Leber congenital amaurosis 6 no assertion criteria provided research
Al Jalila Children's Genomics Center, Al Jalila Childrens Speciality Hospital RCV000171128 SCV001984513 pathogenic Leber congenital amaurosis 6 2020-04-07 flagged submission clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.